Articles written by Lisa Phillips:

Gryphon Investors Gets into Autism Treatment with Learn Behavioral

Learn Behavioral, formerly Learn-It Systems, has a new owner. Gryphon Investors acquired a majority stake in the behavioral health company from LLR Partners in mid-March. Financial terms weren’t disclosed, of course, but the deal wasn’t cheap. This is Gryphon’s first investment in the Behavioral Health Care space. LLR put the company up for sale in late October […]

Social Determinants of Health Network Acquired by Signify

“Social determinants of health” is healthcare’s latest Phrase of the Year. It made its mark at the January 2019 J.P. Morgan Healthcare Conference in San Francisco and has now turned up in a deal announcement. It’s only the first of many, we’re sure. March 15 marked Signify Health‘s first acquisition since New Mountain Capital stepped […]

ResMed Moves into South Korea

Sleep apnea doesn’t discriminate. The condition occurs everywhere, and that’s where ResMed, Inc. (NYSE: RMD) is going. On March 8, the medical device maker bought HB Healthcare in Seoul, South Korea, for an undisclosed amount. HB provides home medical equipment provider and serves both reimbursed and cash-pay customers to assist with sleep apnea, chronic obstructive pulmonary disease […]

Cambia Health Combines (Not Merges) with BCBS of North Carolina

Managed care deals have fallen off the radar recently. In all of 2018, we saw just 25 announcements, down 51% from the year before. The marketplace is certainly undergoing significant changes, as CVS Health (NYSE: CVS) moves ahead with its new subsidiary, Aetna, to create Health Hubs within its retail stores. That combination took Aetna […]

Home Health & Hospice Is Primed for Consolidation

The Home Health & Hospice sector is far less fragmented than it was just five years ago. The sector has seen a lot of activity, thanks to the push by payors to move patients towards lower-cost post-acute care settings. That has attracted a lot of investor interest in recent years, and 2018 proved to be […]

Bausch Health Buys Bankrupt Synergy Pharmaceuticals

Bausch Health Companies Inc. (NYSE: BHC) is back on the acquisition trail. It’s recent target is Synergy Pharmaceuticals Inc., (NASDAQ: SGYP), a New York City-based biopharma focused on novel gastrointestinal (GI) therapies. Its flagship product, Trulance (plecanatide) is a once-daily tablet approved for adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. Synergy […]

U.S. Renal Care Gets Big New Backers

U.S. Renal Care has new owners, as of February 13. It marks the first renal-related transaction in 2019 and it won’t be the last. The national dialysis provider was backed by a consortium of private equity firms such as Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates and Cressey & Company. Stepping in […]

Healthcare Deal Volume Got a Jump Start in January

January was a fairly busy month for healthcare M&A. Preliminary data shows 133 deals reported, nearly equal to December’s 136. The momentum coming out of the fourth quarter spilled into the new year and even without a big boost in deal announcements from the J.P. Morgan Healthcare Conference, consolidation in the industry seems to be […]